Navigation Links
Golden Meditech Repurchases Shares
Date:12/21/2011

HONG KONG, Dec. 21, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings Limited ("Golden Meditech" or the "Group," - 801.HK; 910801.TW), China's leading integrated healthcare enterprise, today announced that the Group has repurchased a total of 9,940,000 shares in December 2011, equivalent to 0.49% of the Group's total outstanding shares at a weighted average price of HK$0.84 per share.Mr. KAM Yuen, Chairman and Chief Executive Officer of the Group, said, "Our recently announced interim results for the first six months of the financial year points to a positive outlook for our operations especially in the healthcare services segment, while our medical devices segment, being a leading name in the medical devices industry in China has also been performing in-line with our expectations.  As a result of a volatile global capitals market, however, we believe the Company's current share price do not adequately reflect the true value of the underlying operation.  Hence to reciprocate our shareholders, the Company has repurchased its shares from the open market.  We will continue to monitor our share price and undertake appropriate actions to repurchase shares when appropriate in consideration to the benefit of our shareholders.

Mr. Kam continued, "As the founding shareholder of the Company, my family and I have been accumulating the Company's shares from the market and now own 21.64%.  I believe that once the market stabilises, the intrinsic value of the Company's will be better reflected in its share price."

About Golden Meditech Holdings LimitedGolden Meditech Holdings Limited is China's leading integrated-healthcare devices and service operator, and the first medical device enterprise that was publicly listed outside of the PRC on the Stock Exchange of Hong Kong Limited (HKEx) and the Taiwan Stock Exchange (TSE).  Golden Meditech is a first-mover in China, having established dominant positions in medical devices and healthcare services markets over the years, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities.  Going forward, the Group will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.

For inquiries, please contact the Investor Relations Department:Golden Meditech Holdings LimitedAddress:

48/F, Bank of China Tower, 1 Garden Road, Central, Hong KongTel:  

+852-3605-8180Fax:  

+852-3605-8181Email:

ir@goldenmeditech.com
'/>"/>

SOURCE Golden Meditech Holdings Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartSine® Technologies Now Exclusive Provider of Lifesaving AEDs to Golden LivingCenters
2. Golden Meditech FY2011-12 Interim Results
3. Golden Meditech Chairman Increases Stake in Company
4. Golden Meditech Increase Stake in NYSE-listed Affiliate - China Cord Blood Corporation to 40.9%
5. Golden Meditech Disposes of 2.0% Stake in FunTalk China for US$15 Million
6. Golden Meditech Celebrates Grand Opening of Taiwan Representative Office
7. Golden Meditech FY2010-11 Annual Results
8. Golden Meditech Acquires Shanghai East International Medical Centre
9. Golden Meditech to Increase Stake in NYSE-listed Affiliate -- China Cord Blood Corporation to 39.5%
10. Golden Meditech Chairman Increases Stake in Company
11. Fenwal, Golden Meditech Complete Definitive Agreement to Form Joint Venture in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , Jan. 19, 2017 The Global Therapy ... and access to partnering deals and agreements entered into ... in partnering deals - Top deals by value - ... development, technology type The report provides understanding and ... by the world,s leading healthcare companies. The report ...
(Date:1/19/2017)... Report Details ... Alzheimer,s Disease Therapeutics and ... our new study reveals trends, R&D progress, and predicted ... the Alzheimer,s disease therapeutics and diagnostics market. Our new ... - How is the Alzheimer,s disease therapeutics and diagnostics ...
(Date:1/19/2017)... 2017  Stealth BioTherapeutics Inc. ( Stealth ), a ... today announced new additions to its senior leadership team: ... Officer, and Daniel Geffken as interim Chief ... Carr , Pharm.D. has been promoted to Chief Clinical ... welcome Doug and Daniel to our management team, as ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... January 20, 2017 , ... Bionic Sports Nutrition LLC, ... of life, announced it had a successful January ECRM Trade Show in Hilton Head, ... United States, which allows it to provide its products to all clients at reasonable ...
(Date:1/20/2017)... ... January 20, 2017 , ... "TransFlare 4K Mystique comes with 44 colorful mysterious ... X," said Christina Austin - CEO of Pixel Film Studios. , TransFlare 4K ... 4K Mystique lens flare and light leak transitions have a very high-dynamic range for ...
(Date:1/20/2017)... ... 20, 2017 , ... “I Forgive You”: a fine examination of how God handles sin, ... creation of published author, Stephen Miller, who, for over ten long years has been waiting ... Born in Trinidad and Tobago, he has been serving the Lord for over twenty years, ...
(Date:1/20/2017)... ... 2017 , ... “The Land of More and More”: a brilliant story ... and shares the simple and achievable answer. “The Land of More and More” is ... Missionary Church in Angola, Indiana where he works with the children’s ministry department. ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... expansion and facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. ... demand of physicians and patients throughout the United States for high-quality human ...
Breaking Medicine News(10 mins):